Group A Streptococcal M1 Protein Sequesters Cathelicidin to Evade Innate Immune Killing

Cell Host and Microbe

Volumn 18, Issue 4, 2015, Pages 471-477

  LaRock, Christopher N ^a   Döhrmann, Simon ^a   Todd, Jordan ^a   Corriden, Ross ^a   Olson, Joshua ^a   Johannssen, Timo ^d,e   Lepenies, Bernd ^d,e,f   Gallo, Richard L ^a,b   Ghosh, Partho ^a   Nizet, Victor ^a,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b San Diego   (United States)

^c UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^d MAX PLANCK INSTITUTE OF COLLOIDS AND INTERFACES   (Germany)

^e FREIE UNIVERSITÄT BERLIN   (Germany)

^f UNIVERSITY OF VETERINARY MEDICINE HANNOVER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL PROTEIN; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; PROTEIN M1; UNCLASSIFIED DRUG; ANTIMICROBIAL CATIONIC PEPTIDE; BACTERIAL ANTIGEN; CAP18 LIPOPOLYSACCHARIDE-BINDING PROTEIN; CARRIER PROTEIN; OUTER MEMBRANE PROTEIN; PROTEIN BINDING; STREPTOCOCCAL M PROTEIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC RESISTANCE; ANTIMICROBIAL ACTIVITY; ARTICLE; BACTERICIDAL ACTIVITY; BACTERIUM ISOLATE; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; HOST RESISTANCE; INNATE IMMUNITY; MOUSE; NECROTIZING FASCIITIS; NEUTROPHIL; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; STREPTOCOCCUS GROUP A; ANIMAL; ANTAGONISTS AND INHIBITORS; BACTERIAL SKIN DISEASE; DISEASE MODEL; HUMAN; IMMUNE EVASION; IMMUNOLOGY; METABOLISM; MICROBIOLOGY; PATHOLOGY; STREPTOCOCCUS INFECTION; STREPTOCOCCUS PYOGENES;

ANIMALS; ANTIGENS, BACTERIAL; ANTIMICROBIAL CATIONIC PEPTIDES; BACTERIAL OUTER MEMBRANE PROTEINS; CARRIER PROTEINS; DISEASE MODELS, ANIMAL; HUMANS; IMMUNE EVASION; MICE; PROTEIN BINDING; SKIN DISEASES, BACTERIAL; STREPTOCOCCAL INFECTIONS; STREPTOCOCCUS PYOGENES;

EID: 84944198769     PISSN: 19313128     EISSN: 19346069     Source Type: Journal    
DOI: 10.1016/j.chom.2015.09.004     Document Type: Article

References (34)

1. S.M. Alalwani, J. Sierigk, C. Herr, O. Pinkenburg, R. Gallo, C. Vogelmeier, and R. Bals The antimicrobial peptide LL-37 modulates the inflammatory and host defense response of human neutrophils Eur. J. Immunol. 40 2010 1118 1126
2. R.K. Aziz, and M. Kotb Rise and persistence of global M1T1 clone of Streptococcus pyogenes Emerg. Infect. Dis. 14 2008 1511 1517
3. P. Bergman, L. Johansson, H. Wan, A. Jones, R.L. Gallo, G.H. Gudmundsson, T. Hökfelt, A.-B. Jonsson, and B. Agerberth Induction of the antimicrobial peptide CRAMP in the blood-brain barrier and meninges after meningococcal infection Infect. Immun. 74 2006 6982 6991
4. J.R. Carapetis, A.C. Steer, E.K. Mulholland, and M. Weber The global burden of group A streptococcal diseases Lancet Infect. Dis. 5 2005 685 694
5. M. Chromek, Z. Slamová, P. Bergman, L. Kovács, L. Podracká, I. Ehrén, T. Hökfelt, G.H. Gudmundsson, R.L. Gallo, B. Agerberth, and A. Brauner The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection Nat. Med. 12 2006 636 641
6. Q. De Yang, A.P. Chen, G.M. Schmidt, J.M. Anderson, J. Wang, J. Wooters, Oppenheim, and O. Chertov LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells J. Exp. Med. 192 2000 1069 1074
7. A. Di Nardo, K. Yamasaki, R.A. Dorschner, Y. Lai, and R.L. Gallo Mast cell cathelicidin antimicrobial peptide prevents invasive group A Streptococcus infection of the skin J. Immunol. 180 2008 7565 7573
8. R.A. Dorschner, V.K. Pestonjamasp, S. Tamakuwala, T. Ohtake, J. Rudisill, V. Nizet, B. Agerberth, G.H. Gudmundsson, and R.L. Gallo Cutaneous injury induces the release of cathelicidin anti-microbial peptides active against group A Streptococcus J. Invest. Dermatol. 117 2001 91 97
9. V.U. Emelianov, F.G. Bechara, R. Gläser, E.A. Langan, W.M. Taungjaruwinai, J.M. Schröder, K.C. Meyer, and R. Paus Immunohistological pointers to a possible role for excessive cathelicidin (LL-37) expression by apocrine sweat glands in the pathogenesis of hidradenitis suppurativa/acne inversa Br. J. Dermatol. 166 2012 1023 1034
10. M.J. Goldman, G.M. Anderson, E.D. Stolzenberg, U.P. Kari, M. Zasloff, and J.M. Wilson Human β-defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis Cell 88 1997 553 560
11. E. Hertzén, L. Johansson, R. Wallin, H. Schmidt, M. Kroll, A.P. Rehn, M. Kotb, M. Mörgelin, and A. Norrby-Teglund M1 protein-dependent intracellular trafficking promotes persistence and replication of Streptococcus pyogenes in macrophages J. Innate Immun. 2 2010 534 545
12. L.C. Huang, R.Y. Reins, R.L. Gallo, and A.M. McDermott Cathelicidin-deficient (Cnlp -/-) mice show increased susceptibility to Pseudomonas aeruginosa keratitis Invest. Ophthalmol. Vis. Sci. 48 2007 4498 4508
13. M.A. Kovach, M.N. Ballinger, M.W. Newstead, X. Zeng, U. Bhan, F.S. Yu, B.B. Moore, R.L. Gallo, and T.J. Standiford Cathelicidin-related antimicrobial peptide is required for effective lung mucosal immunity in Gram-negative bacterial pneumonia J. Immunol. 189 2012 304 311
14. Y. Lai, and R.L. Gallo AMPed up immunity: how antimicrobial peptides have multiple roles in immune defense Trends Immunol. 30 2009 131 141
15. C.N. LaRock, and V. Nizet Cationic antimicrobial peptide resistance mechanisms of streptococcal pathogens Biochim. Biophys. Acta. 2015 10.1016/j.bbamem.2015.02.010 Published online February 17, 2015
16. X. Lauth, M. von Köckritz-Blickwede, C.W. McKnight, S. Myskowski, A.S. Zinkernagel, B. Beall, P. Ghosh, R.L. Gallo, and V. Nizet M1 protein allows Group A streptococcal survival in phagocyte extracellular traps through cathelicidin inhibition J. Innate Immun. 1 2009 202 214
17. P.T. Liu, S. Stenger, H. Li, L. Wenzel, B.H. Tan, S.R. Krutzik, M.T. Ochoa, J. Schauber, K. Wu, C. Meinken, and et al. Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response Science 311 2006 1770 1773
18. P. Macheboeuf, C. Buffalo, C.Y. Fu, A.S. Zinkernagel, J.N. Cole, J.E. Johnson, V. Nizet, and P. Ghosh Streptococcal M1 protein constructs a pathological host fibrinogen network Nature 472 2011 64 68
19. D.J. McMillan, P.A. Drèze, T. Vu, D.E. Bessen, J. Guglielmini, A.C. Steer, J.R. Carapetis, L. Van Melderen, K.S. Sriprakash, and P.R. Smeesters Updated model of group A Streptococcus M proteins based on a comprehensive worldwide study Clin. Microbiol. Infect. 19 2013 E222 E229
20. C. McKnight, A.S. Zinkernagel, P. Macheboeuf, M.W. Cunningham, V. Nizet, and P. Ghosh Coiled-coil irregularities and instabilities in group A Streptococcus M1 are required for virulence Science 319 2008 1405 1408
21. M. Murakami, B. Lopez-Garcia, M. Braff, R.A. Dorschner, and R.L. Gallo Postsecretory processing generates multiple cathelicidins for enhanced topical antimicrobial defense J. Immunol. 172 2004 3070 3077
22. A. Neumann, E.T. Berends, A. Nerlich, E.M. Molhoek, R.L. Gallo, T. Meerloo, V. Nizet, H.Y. Naim, and M. von Köckritz-Blickwede The antimicrobial peptide LL-37 facilitates the formation of neutrophil extracellular traps Biochem. J. 464 2014 3 11
23. V. Nizet, T. Ohtake, X. Lauth, J. Trowbridge, J. Rudisill, R.A. Dorschner, V. Pestonjamasp, J. Piraino, K. Huttner, and R.L. Gallo Innate antimicrobial peptide protects the skin from invasive bacterial infection Nature 414 2001 454 457
24. G.N. Phillips Jr., P.F. Flicker, C. Cohen, B.N. Manjula, and V.A. Fischetti Streptococcal M protein: α-helical coiled-coil structure and arrangement on the cell surface Proc. Natl. Acad. Sci. USA 78 1981 4689 4693
25. K. Pütsep, G. Carlsson, H.G. Boman, and M. Andersson Deficiency of antibacterial peptides in patients with morbus Kostmann: an observation study Lancet 360 2002 1144 1149
26. A. Severin, E. Nickbarg, J. Wooters, S.A. Quazi, Y.V. Matsuka, E. Murphy, I.K. Moutsatsos, R.J. Zagursky, and S.B. Olmsted Proteomic analysis and identification of Streptococcus pyogenes surface-associated proteins J. Bacteriol. 189 2007 1514 1522
27. O. Sørensen, T. Bratt, A.H. Johnsen, M.T. Madsen, and N. Borregaard The human antibacterial cathelicidin, hCAP-18, is bound to lipoproteins in plasma J. Biol. Chem. 274 1999 22445 22451
28. O.E. Sørensen, P. Follin, A.H. Johnsen, J. Calafat, G.S. Tjabringa, P.S. Hiemstra, and N. Borregaard Human cathelicidin, hCAP-18, is processed to the antimicrobial peptide LL-37 by extracellular cleavage with proteinase 3 Blood 97 2001 3951 3959
29. C. Sun, M. Zhu, Z. Yang, X. Pan, Y. Zhang, Q. Wang, and W. Xiao LL-37 secreted by epithelium promotes fibroblast collagen production: a potential mechanism of small airway remodeling in chronic obstructive pulmonary disease Lab. Invest. 94 2014 991 1002
30. M.J. Walker, T.C. Barnett, J.D. McArthur, J.N. Cole, C.M. Gillen, A. Henningham, K.S. Sriprakash, M.L. Sanderson-Smith, and V. Nizet Disease manifestations and pathogenic mechanisms of group A Streptococcus Clin. Microbiol. Rev. 27 2014 264 301
31. J.H. Wong, X.J. Ye, and T.B. Ng Cathelicidins: peptides with antimicrobial, immunomodulatory, anti-inflammatory, angiogenic, anticancer and procancer activities Curr. Protein Pept. Sci. 14 2013 504 514
32. K. Yamasaki, J. Schauber, A. Coda, H. Lin, R.A. Dorschner, N.M. Schechter, C. Bonnart, P. Descargues, A. Hovnanian, and R.L. Gallo Kallikrein-mediated proteolysis regulates the antimicrobial effects of cathelicidins in skin FASEB J. 20 2006 2068 2080
33. K. Yamasaki, A. Di Nardo, A. Bardan, M. Murakami, T. Ohtake, A. Coda, R.A. Dorschner, C. Bonnart, P. Descargues, A. Hovnanian, and et al. Increased serine protease activity and cathelicidin promotes skin inflammation in rosacea Nat. Med. 13 2007 975 980
34. M. Zaiou, V. Nizet, and R.L. Gallo Antimicrobial and protease inhibitory functions of the human cathelicidin (hCAP18/LL-37) prosequence J. Invest. Dermatol. 120 2003 810 816